Trac Services | IDMP | Identification of Medicinal Products | TRAC Services
page-template,page-template-full_width,page-template-full_width-php,page,page-id-7168,page-idmp,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-7.5,wpb-js-composer js-comp-ver-5.1.1,vc_responsive

Identification of Medicinal Products (IDMP)

The consultancy for global, pharmaceutical regulatory affairs

We support pharmaceutical companies comply with the Identification of Medicinal Products (IDMP), EU legislation.

As mandated by EU legislation, Identification of Medicinal Products (IDMP) was  implemented in July 2016. The main purpose is to standardise the way the pharmaceutical industry refers to medicinal products, providing a universal identification for drugs that can be referenced in individual case safety reports. IDMP is much more comprehensive then, and replaces the eXtended Eudravigilance Medicinal Product Dictionary (XEVMPD) as the submission standard.

Devised by the International Organization for Standardisation (ISO), the IDMP is comprised of five information management standards on the use, consumption and packaging of drugs. The standards specifies ‘definitions in terms for all data elements required to uniquely and with certainty identify medical products for human use’.


IDMP Regulations Presentation

Our second update on this rapidly developing topic comes in the form of a presentation adapted from the EMIG IDMP Regulations Meeting TRAC presented at.  This event was delivered in conjunction with Andrew Marr, of the Marr Consultancy a recognised expert in this field.

The presentation provides:

  • an introduction to ISO IDMP
  • the results of TRAC’s survey on preparation and implementation challenges
  • the latest updates from the EU ISO IDMP task force
  • practical tips on how to tackle the top five issues highlighted by the survey
Read our IDMP Presentation

IDMP Implementation Survey

Find out what the top 5 concerns are regarding implementing IDMP, from an EU perspective, click on the link opposite and read Lisa Pascoe’s update on how these concerns can be addressed.

Read the results of our survey

We will continue to provide updates to help companies comply with the IDMP legislation. If you want to be the first to receive this additional content please sign up to our newsletter  or bookmark this page as we will be updating the content regularly.

We hope our reputation and website inspire you to get in touch!